Fact CheckerSign in

NCT05368571Active, not recruiting

CHOICES-TEEN Randomized Controlled Trial

CHOICES-TEEN: Efficacy of a Bundled Risk Reduction Intervention for Juvenile Justice Females

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
400 (estimated)
First submitted
6 May 2022
Start date
8 Apr 2022
Primary completion date
28 Feb 2027
Lead sponsor
Danielle Parrish
Diseases
HIV
NCT number
NCT05368571

What you commit to

  • Study type: Interventional
  • Planned participants: 400
  • From 8 Apr 2022 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • severe cognitive and/or psychiatric impairment that precludes cooperation with study protocol, per judgement of the interventionist or research staff

Other

  • do not speak or read/write in English
  • unable to meet study requirements, including follow-up assessments

Who the study is looking for

  • Female adolescents between 14-19 years of age, of any race, who are at risk of substance-exposed pregnancy and HIV/STI will be eligible. Specifically, they must report the following behaviors within the last 3 months:
  • sexual intercourse with a male
  • inconsistent/ineffective condom use AND
  • inconsistent/ineffective contraception use

Age in the registry: 14 years to 19 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Baylor University
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.